Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meta-analysis of Efficacy of Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix

NCT01160185 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01160185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meta-analysis of Efficacy of Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2009
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia